{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:05:30Z","timestamp":1787742330166,"version":"build-2784847793"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"None"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The Nucleocapsid Protein (N Protein) of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV2) is located in the viral core. Immunoglobulin G (IgG) targeting N protein is detectable in the serum of infected patients. The effect of high titers of IgG against N-protein on clinical outcomes of SARS-CoV2 disease has not been described. We studied 400 RT-PCR confirmed SARS-CoV2 patients to determine independent factors associated with poor outcomes, including Medical Intensive Care Unit (MICU) admission, prolonged MICU stay and hospital admissions, and in-hospital mortality. We also measured serum IgG against the N protein and correlated its concentrations with clinical outcomes. We found that several factors, including Charlson comorbidity Index (CCI), high levels of IL6, and presentation with dyspnea were associated with poor clinical outcomes. It was shown that higher CCI and higher IL6 levels were independently associated with in-hospital mortality. Anti-N protein IgG was detected in the serum of 55 (55%) patients at the time of admission. A high concentration of antibodies, defined as signal to cut off ratio (S\/Co)\u2009&gt;\u20091.5 (75 percentile of all measurements), was found in 25 (25%) patients. The multivariable logistic regression models showed that between being an African American, higher CCI, lymphocyte counts, and S\/Co ratio\u2009&gt;\u20091.5, only S\/Co ratio were independently associated with MICU admission and longer length of stay in hospital. This study recommends that titers of IgG targeting N-protein of SARS-CoV2 at admission is a prognostic factor for the clinical course of disease and should be measured in all patients with SARS-CoV2 infection.<\/jats:p>","DOI":"10.1038\/s41598-021-83108-0","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T17:27:28Z","timestamp":1612978048000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["Role of IgG against N-protein of SARS-CoV2 in COVID19 clinical outcomes"],"prefix":"10.1038","volume":"11","author":[{"given":"Mayank","family":"Batra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runxia","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongxu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile","family":"Clarence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Sofia","family":"Sacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin Nestor","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin Rafa O.","family":"De La Fuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desmond","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayari","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Virginia Perez","family":"Bastidas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Haddadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukunthan","family":"Murthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Santiago","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Kambali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayo H. M.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda","family":"Asif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzaneh","family":"Modarresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Faghihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Mirsaeidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"key":"83108_CR1","doi-asserted-by":"publisher","first-page":"759","DOI":"10.15585\/mmwr.mm6924e2","volume":"69","author":"EK Stokes","year":"2020","unstructured":"Stokes, E. K. et al. Coronavirus disease 2019 case surveillance\u2014United States, January 22\u2013May 30, 2020. MMWR Morb. Mortal Wkly. Rep. 69, 759\u2013765. https:\/\/doi.org\/10.15585\/mmwr.mm6924e2 (2020).","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"83108_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fmed.2020.00231","volume":"7","author":"A Tahvildari","year":"2020","unstructured":"Tahvildari, A. et al. Clinical features, diagnosis, and treatment of COVID-19 in hospitalized patients: a systematic review of case reports and case series. Front. Med. (Lausanne) 7, 231. https:\/\/doi.org\/10.3389\/fmed.2020.00231 (2020).","journal-title":"Front. Med. (Lausanne)"},{"key":"83108_CR3","unstructured":"Mahdy, S. M. & Elshemey, W. M. Quantitative structure-activity relationship and molecular docking revealed a potency of anti-hepatitis C virus drugs against human corona viruses. (2017)."},{"key":"83108_CR4","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1128\/JVI.01394-09","volume":"84","author":"RL Graham","year":"2010","unstructured":"Graham, R. L. & Baric, R. S. Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission. J. Virol. 84, 3134\u20133146 (2010).","journal-title":"J. Virol."},{"key":"83108_CR5","doi-asserted-by":"publisher","first-page":"8127","DOI":"10.1128\/JVI.74.17.8127-8134.2000","volume":"74","author":"K Narayanan","year":"2000","unstructured":"Narayanan, K., Maeda, A., Maeda, J. & Makino, S. Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells. J. Virol. 74, 8127\u20138134 (2000).","journal-title":"J. Virol."},{"key":"83108_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jsb.2010.11.021","volume":"174","author":"BW Neuman","year":"2011","unstructured":"Neuman, B. W. et al. A structural analysis of M protein in coronavirus assembly and morphology. J. Struct. Biol. 174, 11\u201322 (2011).","journal-title":"J. Struct. Biol."},{"key":"83108_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-019-1182-0","volume":"16","author":"D Schoeman","year":"2019","unstructured":"Schoeman, D. & Fielding, B. C. Coronavirus envelope protein: current knowledge. Virol. J. 16, 1\u201322 (2019).","journal-title":"Virol. J."},{"key":"83108_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.meegid.2007.07.004","volume":"8","author":"M Surjit","year":"2008","unstructured":"Surjit, M. & Lal, S. K. The SARS-CoV nucleocapsid protein: a protein with multifarious activities. Infect. Genet. Evol. 8, 397\u2013405. https:\/\/doi.org\/10.1016\/j.meegid.2007.07.004 (2008).","journal-title":"Infect. Genet. Evol."},{"key":"83108_CR9","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.3390\/v6082991","volume":"6","author":"R McBride","year":"2014","unstructured":"McBride, R., Van Zyl, M. & Fielding, B. C. The coronavirus nucleocapsid is a multifunctional protein. Viruses 6, 2991\u20133018 (2014).","journal-title":"Viruses"},{"key":"83108_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/157895","author":"PJ Klasse","year":"2014","unstructured":"Klasse, P. J. Neutralization of virus infectivity by antibodies: old problems in new perspectives. Adv. Biol. https:\/\/doi.org\/10.1155\/2014\/157895 (2014).","journal-title":"Adv. Biol."},{"key":"83108_CR11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41586-020-2538-8","volume":"584","author":"AM Arvin","year":"2020","unstructured":"Arvin, A. M. et al. A perspective on potential antibody-dependent enhancement of SARS-CoV-2. Nature 584, 353\u2013363. https:\/\/doi.org\/10.1038\/s41586-020-2538-8 (2020).","journal-title":"Nature"},{"key":"83108_CR12","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta, P. et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet (London, England) 395, 1033 (2020).","journal-title":"Lancet (London, England)"},{"key":"83108_CR13","doi-asserted-by":"publisher","first-page":"29201","DOI":"10.1038\/srep29201","volume":"6","author":"J Flipse","year":"2016","unstructured":"Flipse, J. et al. Antibody-dependent enhancement of dengue virus infection in primary human macrophages; balancing higher fusion against antiviral responses. Sci. Rep. 6, 29201. https:\/\/doi.org\/10.1038\/srep29201 (2016).","journal-title":"Sci. Rep."},{"key":"83108_CR14","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.29.20041962","author":"T Gao","year":"2020","unstructured":"Gao, T. et al. Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation. MedRxiv https:\/\/doi.org\/10.1101\/2020.03.29.20041962 (2020).","journal-title":"MedRxiv."},{"key":"83108_CR15","doi-asserted-by":"crossref","unstructured":"Cheng, Y. et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney international (2020).","DOI":"10.1101\/2020.02.18.20023242"},{"key":"83108_CR16","unstructured":"Inc., E. D. <http:\/\/www.epitopediagnostics.com\/covid-19-elisa> (2020)."},{"key":"83108_CR17","unstructured":"Inc., E. D. EDI\u2122 Novel Coronavirus COVID-19 ELISA Kit. (2020). <https:\/\/static1.squarespace.com\/static\/52545951e4b021818110f9cf\/t\/5ec31d5ae584561068a600ca\/1589845366430\/KT-1032+RUO+V4.pdf>."},{"key":"83108_CR18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3389\/fmed.2020.00459","volume":"7","author":"MJ Nasiri","year":"2020","unstructured":"Nasiri, M. J. et al. COVID-19 clinical characteristics, and sex-specific risk of mortality: systematic review and meta-analysis. Front. Med. (Lausanne) 7, 459. https:\/\/doi.org\/10.3389\/fmed.2020.00459 (2020).","journal-title":"Front. Med. (Lausanne)"},{"key":"83108_CR19","doi-asserted-by":"publisher","DOI":"10.2196\/23565","author":"M Jarrett","year":"2020","unstructured":"Jarrett, M. et al. Clinical mortality review in a large COVID-19 cohort. J. Med. Internet Res. https:\/\/doi.org\/10.2196\/23565 (2020).","journal-title":"J. Med. Internet Res."},{"key":"83108_CR20","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2020.461","author":"K Sands","year":"2020","unstructured":"Sands, K. et al. Patient characteristics and admitting vital signs associated with COVID-19 related mortality among patients admitted with non-critical illness. Infect. Control Hosp. Epidemiol. https:\/\/doi.org\/10.1017\/ice.2020.461 (2020).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"83108_CR21","doi-asserted-by":"publisher","first-page":"104949","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104949","volume":"29","author":"R Pranata","year":"2020","unstructured":"Pranata, R., Huang, I., Lim, M. A., Wahjoepramono, E. J. & July, J. Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19-systematic review, meta-analysis, and meta-regression. J. Stroke Cerebrovasc. Dis. 29, 104949. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.104949 (2020).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"83108_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson, M. E., Pompei, P., Ales, K. L. & MacKenzie, C. R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40, 373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8 (1987).","journal-title":"J. Chronic Dis."},{"key":"83108_CR23","doi-asserted-by":"publisher","first-page":"e01136","DOI":"10.1002\/cti2.1136","volume":"9","author":"H Hou","year":"2020","unstructured":"Hou, H. et al. Detection of IgM and IgG antibodies in patients with coronavirus disease 2019. Clin. Transl. Immunol. 9, e01136. https:\/\/doi.org\/10.1002\/cti2.1136 (2020).","journal-title":"Clin. Transl. Immunol."},{"key":"83108_CR24","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1080\/22221751.2020.1773324","volume":"9","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. Patterns of IgG and IgM antibody response in COVID-19 patients. Emerg. Microbes. Infect. 9, 1269\u20131274. https:\/\/doi.org\/10.1080\/22221751.2020.1773324 (2020).","journal-title":"Emerg. Microbes. Infect."},{"key":"83108_CR25","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1038\/s41591-018-0186-4","volume":"24","author":"Y Bar-On","year":"2018","unstructured":"Bar-On, Y. et al. Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals. Nat. Med. 24, 1701\u20131707. https:\/\/doi.org\/10.1038\/s41591-018-0186-4 (2018).","journal-title":"Nat. Med."},{"key":"83108_CR26","doi-asserted-by":"publisher","first-page":"7813","DOI":"10.1128\/JVI.00783-15","volume":"89","author":"RB Gombos","year":"2015","unstructured":"Gombos, R. B. et al. Inhibitory effect of individual or combinations of broadly neutralizing antibodies and antiviral reagents against cell-free and cell-to-cell HIV-1 transmission. J. Virol. 89, 7813\u20137828. https:\/\/doi.org\/10.1128\/JVI.00783-15 (2015).","journal-title":"J. Virol."},{"key":"83108_CR27","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1146\/annurev-immunol-032712-095916","volume":"31","author":"D Corti","year":"2013","unstructured":"Corti, D. & Lanzavecchia, A. Broadly neutralizing antiviral antibodies. Annu. Rev. Immunol. 31, 705\u2013742. https:\/\/doi.org\/10.1146\/annurev-immunol-032712-095916 (2013).","journal-title":"Annu. Rev. Immunol."},{"key":"83108_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa505","author":"SB Bradfute","year":"2020","unstructured":"Bradfute, S. B. et al. SARS-CoV-2 neutralizing antibody titers in convalescent plasma and recipients in new Mexico: an open treatment study in COVID-19 patients. J. Infect. Dis. https:\/\/doi.org\/10.1093\/infdis\/jiaa505 (2020).","journal-title":"J. Infect. Dis."},{"key":"83108_CR29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1021\/acsinfecdis.6b00006","volume":"2","author":"Q Wang","year":"2016","unstructured":"Wang, Q. et al. Immunodominant SARS coronavirus epitopes in humans elicited both enhancing and neutralizing effects on infection in non-human primates. ACS Infect. Dis. 2, 361\u2013376. https:\/\/doi.org\/10.1021\/acsinfecdis.6b00006 (2016).","journal-title":"ACS Infect. Dis."},{"key":"83108_CR30","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.4049\/jimmunol.173.6.4050","volume":"173","author":"Y He","year":"2004","unstructured":"He, Y. et al. Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines. J. Immunol. 173, 4050\u20134057. https:\/\/doi.org\/10.4049\/jimmunol.173.6.4050 (2004).","journal-title":"J. Immunol."},{"key":"83108_CR31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/d41573-020-00073-5","volume":"19","author":"T Le Thanh","year":"2020","unstructured":"Le Thanh, T. et al. The COVID-19 vaccine development landscape. Nat. Rev. Drug Discov. 19, 305\u2013306. https:\/\/doi.org\/10.1038\/d41573-020-00073-5 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"83108_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2538-8","author":"AM Arvin","year":"2020","unstructured":"Arvin, A. M. et al. A perspective on potential antibody-dependent enhancement of SARS-CoV-2. Nature https:\/\/doi.org\/10.1038\/s41586-020-2538-8 (2020).","journal-title":"Nature"},{"key":"83108_CR33","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/978-981-15-0602-4_27","volume":"1206","author":"B Cui","year":"2019","unstructured":"Cui, B., Lin, H., Yu, J., Yu, J. & Hu, Z. Autophagy and the immune response. Adv. Exp. Med. Biol. 1206, 595\u2013634. https:\/\/doi.org\/10.1007\/978-981-15-0602-4_27 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"83108_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxaa287","author":"LM Sagardia","year":"2020","unstructured":"Sagardia, L. M. & Daniels, L. M. Thrombolysis and use of argatroban for the treatment of massive pulmonary embolism following anticoagulation failure in a patient with COVID-19. Am. J. Health Syst. Pharm. https:\/\/doi.org\/10.1093\/ajhp\/zxaa287 (2020).","journal-title":"Am. J. Health Syst. Pharm."},{"key":"83108_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/acem.14096","author":"Y Freund","year":"2020","unstructured":"Freund, Y. et al. Association between pulmonary embolism and COVID-19 in D patients undergoing CTPA: the PEPCOV international retrospective study. Acad. Emerg. Med. https:\/\/doi.org\/10.1111\/acem.14096 (2020).","journal-title":"Acad. Emerg. Med."},{"key":"83108_CR36","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1186\/s13054-020-03175-z","volume":"24","author":"SC Liao","year":"2020","unstructured":"Liao, S. C., Shao, S. C., Chen, Y. T., Chen, Y. C. & Hung, M. J. Incidence and mortality of pulmonary embolism in COVID-19: a systematic review and meta-analysis. Crit. Care 24, 464. https:\/\/doi.org\/10.1186\/s13054-020-03175-z (2020).","journal-title":"Crit. Care"},{"key":"83108_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.21037\/atm.2019.03.04","volume":"7","author":"CY Wang","year":"2019","unstructured":"Wang, C. Y. et al. Enhancing autophagy protects platelets in immune thrombocytopenia patients. Ann. Transl. Med. 7, 134. https:\/\/doi.org\/10.21037\/atm.2019.03.04 (2019).","journal-title":"Ann. Transl. Med."},{"key":"83108_CR38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12935-017-0460-4","volume":"17","author":"L Repsold","year":"2017","unstructured":"Repsold, L., Pool, R., Karodia, M., Tintinger, G. & Joubert, A. M. An overview of the role of platelets in angiogenesis, apoptosis and autophagy in chronic myeloid leukaemia. Cancer Cell Int. 17, 89. https:\/\/doi.org\/10.1186\/s12935-017-0460-4 (2017).","journal-title":"Cancer Cell Int."},{"key":"83108_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-019-1665-1","author":"W Li","year":"2020","unstructured":"Li, W. et al. CD49a(+)CD49b(+) NK cells induced by viral infection reflect an activated state of conventional NK cells. Sci. China Life Sci. https:\/\/doi.org\/10.1007\/s11427-019-1665-1 (2020).","journal-title":"Sci. China Life Sci."},{"key":"83108_CR40","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/s41598-018-36972-2","volume":"9","author":"P Sun","year":"2019","unstructured":"Sun, P. et al. NK cells activated through antibody-dependent cell cytotoxicity and armed with degranulation\/IFN-gamma production suppress antibody-dependent enhancement of dengue viral infection. Sci. Rep. 9, 1109. https:\/\/doi.org\/10.1038\/s41598-018-36972-2 (2019).","journal-title":"Sci. Rep."},{"key":"83108_CR41","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3389\/fimmu.2019.00332","volume":"10","author":"MZ Tay","year":"2019","unstructured":"Tay, M. Z., Wiehe, K. & Pollara, J. Antibody-dependent cellular phagocytosis in antiviral immune responses. Front. Immunol. 10, 332. https:\/\/doi.org\/10.3389\/fimmu.2019.00332 (2019).","journal-title":"Front. Immunol."},{"key":"83108_CR42","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1002\/eji.1830260618","volume":"26","author":"S Berger","year":"1996","unstructured":"Berger, S., Ballo, H. & Stutte, H. J. Immune complex-induced interleukin-6, interleukin-10 and prostaglandin secretion by human monocytes: a network of pro- and anti-inflammatory cytokines dependent on the antigen:antibody ratio. Eur. J. Immunol. 26, 1297\u20131301. https:\/\/doi.org\/10.1002\/eji.1830260618 (1996).","journal-title":"Eur. J. Immunol."},{"key":"83108_CR43","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/art.41285","volume":"72","author":"LA Henderson","year":"2020","unstructured":"Henderson, L. A. et al. On the alert for cytokine storm: immunopathology in COVID-19. Arthritis Rheumatol. 72, 1059\u20131063. https:\/\/doi.org\/10.1002\/art.41285 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"83108_CR44","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41426-018-0168-0","volume":"7","author":"N Uno","year":"2018","unstructured":"Uno, N. & Ross, T. M. Dengue virus and the host innate immune response. Emerg. Microbes. Infect. 7, 167. https:\/\/doi.org\/10.1038\/s41426-018-0168-0 (2018).","journal-title":"Emerg. Microbes. Infect."},{"key":"83108_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/infdis\/128.1.15","volume":"128","author":"SB Halstead","year":"1973","unstructured":"Halstead, S. B., Shotwell, H. & Casals, J. Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection. J. Infect. Dis. 128, 15\u201322. https:\/\/doi.org\/10.1093\/infdis\/128.1.15 (1973).","journal-title":"J. Infect. Dis."},{"key":"83108_CR46","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/infdis\/140.4.527","volume":"140","author":"SB Halstead","year":"1979","unstructured":"Halstead, S. B. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J. Infect. Dis. 140, 527\u2013533. https:\/\/doi.org\/10.1093\/infdis\/140.4.527 (1979).","journal-title":"J. Infect. Dis."},{"key":"83108_CR47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/infdis\/128.1.23","volume":"128","author":"NJ Marchette","year":"1973","unstructured":"Marchette, N. J., Halstead, S. B., Falkler, W. A. Jr., Stenhouse, A. & Nash, D. Studies on the pathogenesis of dengue infection in monkeys. 3. Sequential distribution of virus in primary and heterologous infections. J. Infect. Dis. 128, 23\u201330. https:\/\/doi.org\/10.1093\/infdis\/128.1.23 (1973).","journal-title":"J. Infect. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83108-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83108-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83108-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T22:32:44Z","timestamp":1670020364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83108-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,10]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["83108"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-83108-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.09.23.20197251","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,10]]},"assertion":[{"value":"29 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Farzaneh Modarresi and Dr. Mohammad Faghihi are employees of Express Gene. Other authors have no conflict of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3455"}}